DEPRESSION IN ADOLESCENTS - MYTH OR REALITY?
Keywords:depression, adolescence, antidepressant, psychosomatic
Introduction: Adolescence is a period of changes, making this phase more vulnerable to psychological disturbances. The Depressive Disorder is a clinical entity increasingly prevalent and may be a precursor of adult psychopathology.
Objectives: To evaluate the prevalence and characterize the population of adolescents with depressive syndrome in an adolescent consultation.
Methods: Retrospective and analytical study, based on data obtained from 91 medical records of patients followed in the adolescence office with the diagnosis of depressive syndrome in the period of January 2003 to December 2011.
Results: The diagnosis of depressive syndrome was made in 91 adolescents. There was a predominance of females. The average age of diagnosis was 14.8 years. The adolescents were referred mainly from the Primary Health Care and Emergency Paediatric (26.4 and 22%, respectively). The main symptoms at presentation were sadness / emotional lability / tearfulness (61.5%). Psychosomatic symptoms were quite prevalent accounting for 30.8%. In 64.8% of cases an unfavourable context was identified, and the family conl icts were the most frequent (38.5%). There was suicidal ideation in 28.6% of cases with para-suicide in 21%. In 60% it was necessary collaboration from other specialties (71% child psychiatry). Medication was started in 76.9% of adolescents, the most widely used drug was fluvoxamine.
Conclusion: Depressive disorder in adolescents has been increasing in recent years. Frequently, the Primary Health Care physicians are the first to contact with this situation. It is important the early identiÞ cation of adolescents at risk of developing this disease.
Cook MN, Peterson J, Sheldon C. Adolescent depression:
an update and guide to clinical decision making. Psychiatry
; 6:17 -31.
Zuckerbrot RA, Cheung AH, Jensen PS, Stein RE, Laraque D.
GLAD -PC Steering Group. Guidelines for adolescent depression
in primary care (GLAD -PC): I. identiÞ cation, assessment,
and initial management. Pediatrics 2007; 120:e1299 -e1312.
Lobin L. Depression in adolescents: epidemiology, clinical manifestations
and diagnosis. Uptodate. Versão 19, Janeiro, 2012
(Acedido em 10/02/2012). Disponível em: www.uptodate.com.
Fleming JE, Offord DR. Epidemiology of childhood depressive
disorders: a critical review. J Am Acad Child Adolesc
Psychiatry 1990; 29:571 -80.
Lewinsohn PM, Clarke GN, Seeley JR, Rohde P. Major depression
in community adolescents: age at onset, episode
duration, and time to recurrence. J Am Acad Child Adolesc
Psychiatry 1994; 33:809 -18.
Lewinsohn PM, Rohde P, Klein DN, Seeley JR. Natural course
of adolescent major depressive disorder: I. Continuity into
young adulthood. J Am Acad Child Adolesc Psychiatry 1999;
Rao U, Hammen C, Daley SE. Continuity of depression during
the transition to adulthood: a 5 -year longitudinal study
of young women. J Am Acad Child Adolesc Psychiatry 1999;
Bonin L, Moreland CS. Overview of treatment for adolescent
depression. Uptodate. Versão 19, Janeiro, 2012 (Acedido em
/02/2012). Disponível em: www.uptodate.com
American Psychiatric Association. DSM IV -TR – Manual de
Diagnóstico e estatística das Perturbações Mentais. 4ª ed.
Lisboa: Climepsi editores, 2002.
Saluja G, Iachan R, Scheidt PC, Overpeck MD, Sun W, Giedd
JN. Prevalence of and risk factors for depressive symptoms
among young adolescents. Arch Pediatr Adolesc Med 2004;
Birmaher B, Brent D, AACAP Work Group on Quality Issues,
Bernet W, Bukstein O, Walter H, et al. Practice parameter for
the assessment and treatment of children and adolescents
with depressive disorders. J Am Acad Child Adolesc Psychiatry
; 46:1503 -26.
March J, Silva S, Petrycki S, Curry J, Wells K, Fairbank J, et
al. Fluoxetine, cognitive -behavioral therapy, and their combination
for adolescents with depression: Treatment for Adolescents
With Depression Study (TADS) randomized controlled
trial. JAMA 2004; 292:807 -20.
March JS, Silva S, Petrycki S, Curry J, Wells K, Fairbank J,
et al. The Treatment for Adolescents With Depression Study
(TADS): long -term effectiveness and safety outcomes. Arch
Gen Psychiatry 2007; 64:1132 -43.
Moreland CS, Bonin L. Psychopharmacological treatment for
adolescent depression. Uptodate. Versão 19, Janeiro, 2012
(Acedido em 10/02/2012). Disponível em: www.uptodate.com
Souza LDM, Silva RS, Goodoy RV, Cruzeiro ALS, Faria AD,
Pinheiro RT, et al. Sintomatologia depressiva em adolescentes
iniciais – estudo de base populacional. J Bras Psiquiatr
; 57:261 -6.
Oliveira -Brochado F, Oliveira -Brochado A. Estudo da presença
de sintomatologia depressiva na adolescência. Revista
Portuguesa de Saúde Pública 2008; 26:27 -36.
Cordeiro R, Claudino J, Arriaga M. Depressão e suporte social
em adolescentes e jovens adultos. Revista Iberoamericana
de Educación 2006; 39:1 -9.
Cardoso P, Rodrigues C, Vilar A. Prevalência de sintomas
depressivos em adolescentes portugueses. Aná Psicológica
; 22:667 -75.
Birmaher B, Ryan ND, Williamson DE, Brent DA, Kaufman
J, Dahl RE, et al. Childhood and adolescent depression: a
review of the past 10 years. Part I. J Am Acad Child Adolesc
Psychiatry 1996; 35:1427 -39.
Aragão TA, Coutinho MP, Araujo LF, Castanha AR. Uma perspectiva
psicossocial da sintomatologia depressiva na adolescência.
Ciênc Saúde Coletiva 2009; 14:395 -405.
Reppold CT. Prevalência de indicadores de depressão entre
adolescentes no Rio Grande do Sul. Aval psicol 2003; 2:175 -84.
Bahls SC. Aspetos clínicos da depressão em crianças e adolescentes.
J Pediatr 2002; 78: 359 -66.
Brito I. Ansiedade e depressão na adolescência. Rev Port
Clin Geral 2011; 27:208 -14.
Fonseca MHG, Ferreira RA, Fonseca SG. Prevalência de sintomas
depressivos em escolares. Pediatria 2005; 27:223 -32.
Avanci JQ, Assis SG, Oliveira R. Sintomas depressivos na
adolescência: estudo sobre fatores psicossociais em amostra
de escolares de um município do Rio de Janeiro, Brasil.
Cad Saúde Pública 2008; 24:2334 -46.
Uthman OA, Abdulmalik J. Comparative efÞ cacy and acceptability
of pharmacotherapeutic agents for anxiety disorders
in children and adolescents: a mixed treatment comparison
meta -analysis. Curr Med Res Opin 2010; 26:53 -9.
Maršani VB, Margeti BA, Margeti B. Outpatient treatment
of children and adolescents with antidepressants in Croatia.
Int J Psychiatry Clin Pract 2012; 16:214 -22.
Sepehrmanesh Z, Alavi A, Arabgol F. Fluvoxamine for the
Treatment of Child and Adolescent. Depression: An Open Label
Trial. Iran J Psychiatry 2008; 3:11 -5.
Walkup J, Labellarte M, Riddle M, Pine D, Greenhill L, Klein
R, et al. Fluvoxamine for the treatment of anxiety disorders in
children and adolescents. N Engl J Med 2001; 344:1279 -85.
How to Cite
Copyright and access
This journal offers immediate free access to its content, following the principle that providing free scientific knowledge to the public provides greater global democratization of knowledge.
The works are licensed under a Creative Commons Attribution Non-commercial 4.0 International license.
Nascer e Crescer – Birth and Growth Medical Journal do not charge any submission or processing fee to the articles submitted.